Sign in

CIK 0001635088

  • Large accelerated filer

Roivant Sciences Ltd.

Sign in to watch
Ticker
ROIV
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Mar 31
Incorporated
Bermuda
Entity type
Operating
EIN
981173944
Phone
+44 12955950
Business address
7TH FLOOR, 50 BROADWAY, LONDON, United Kingdom, SW1H 0DB
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$70,369,463
in 12 filings, $45.5M under 10b5-1 plans

Net −$70,369,463. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2024-04-22 Kumar Rakhi Chief Accounting Officer Grant or award −38,685 216,573
2024-04-22 Kumar Rakhi Chief Accounting Officer Grant or award · Stock Option (Right to Buy) +230,548 230,548
2024-04-22 Pulik Richard CFO Grant or award +38,685 297,382
2024-04-22 Pulik Richard CFO Grant or award · Stock Option (Right to Buy) +302,594 302,594
2024-04-20 Gline Matthew CEO Shares withheld for taxes 10b5-1 −10,945 $10.46 $114K 1,153,706
2024-04-20 Pulik Richard CFO Shares withheld for taxes 10b5-1 −8,515 $10.46 $89K 258,697
2024-04-20 Kumar Rakhi Chief Accounting Officer Shares withheld for taxes 10b5-1 −9,881 $10.46 $103K 177,888
2024-04-20 Venker Eric President & COO Shares withheld for taxes 10b5-1 −16,002 $10.46 $167K 484,200
2024-03-30 Sukhatme Mayukh Pres&Chief Investment Officer Option exercise 10b5-1 +729,081 4,018,196
2024-03-30 Sukhatme Mayukh Pres&Chief Investment Officer Shares withheld for taxes 10b5-1 −366,211 $10.54 $3.9M 3,651,985
2024-03-30 Sukhatme Mayukh Pres&Chief Investment Officer Option exercise · Capped Value Appreciation Rights 10b5-1 −1,856,163 $6.40 $11.9M 0
2024-03-30 Gline Matthew CEO Option exercise 10b5-1 +390,579 1,380,642
2024-03-30 Gline Matthew CEO Shares withheld for taxes 10b5-1 −215,991 $10.54 $2.3M 1,164,651
2024-03-30 Gline Matthew CEO Option exercise · Capped Value Appreciation Rights 10b5-1 −994,373 $6.40 $6.4M 0
2024-03-28 Pulik Richard CFO Shares withheld for taxes 10b5-1 −2,341 $10.54 $25K 267,212
2024-03-20 Venker Eric President & COO Shares withheld for taxes 10b5-1 −16,003 $10.01 $160K 500,202
2024-03-20 Kumar Rakhi Chief Accounting Officer Shares withheld for taxes 10b5-1 −1,506 $10.01 $15K 187,769
2024-03-20 Gline Matthew CEO Shares withheld for taxes 10b5-1 −10,945 $10.01 $110K 990,063
2024-03-07 MANCHESTER KEITH S Director Other disposition −11,077,765 14,646,796
2024-03-07 MANCHESTER KEITH S Director Other disposition −11,325,233 23,105,358

Page 32 of 38 · 748 trades